BLOK Technologies Announces Changes in Directors
VANCOUVER, British Columbia, Jan. 14, 2019 (GLOBE NEWSWIRE) — BLOK Technologies Inc. (“BLOK Tech” or the “Company”) (CSE: BLK) (OTC: […]
JCPenney Announces Executive Leadership Changes
PLANO, Texas – (Jan. 14, 2019) – J. C. Penney Company, Inc. (NYSE: JCP) today announced a series of leadership […]
RLH Corporation Appoints Julie Shiflett Chief Financial Officer
DENVER, Jan. 14, 2019 (GLOBE NEWSWIRE) — RLH Corporation (NYSE:RLH) announced today the appointment of Julie Shiflett as its Executive […]
ESCO Technologies Management Cancels Presentation at the 21st Annual Needham Growth Conference
St. Louis, Jan. 14, 2019 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) has cancelled its webcast at the 21st […]
ARMOUR Residential REIT, Inc. Announces Public Offering of 5,000,000 Shares of Common Stock
VERO BEACH, Florida, Jan. 14, 2019 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR, ARR PrA and ARR PrB) […]
KEMET Announces Cost Improvement Actions in Film and Electrolytic Segment
FORT LAUDERDALE, Fla., Jan. 14, 2019 (GLOBE NEWSWIRE) — KEMET Corporation, a Delaware corporation (“KEMET” or the “Company”), a leading […]
BCB Bancorp, Inc. Declares Cash Dividend of $0.14 Per Share
BAYONNE, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”) (NASDAQ: BCBP), the holding company for BCB […]
Oaktree Strategic Income Corporation Schedules First Fiscal Quarter Earnings Conference Call for February 7, 2019
12:30 p.m. Eastern Time / 9:30 a.m. Pacific Time LOS ANGELES, Jan. 14, 2019 (GLOBE NEWSWIRE) — Oaktree Strategic Income […]
Oaktree Specialty Lending Corporation Schedules First Fiscal Quarter Earnings Conference Call for February 7, 2019
11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time LOS ANGELES, CA, Jan. 14, 2019 (GLOBE NEWSWIRE) — Oaktree Specialty […]
BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma
CAMBRIDGE, Mass. and BEIJING, China, Jan. 14, 2019 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical […]
